chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Staphylococcal infection, Staphylococcus test negative, Staphylococcus test positive, Tenderness, Urinary casts present
Clinical narrative: The patient is a 55 y.o. female with a PMHx of CVA with residual left facial drop, anxiety, DDD, HLD, HTN and nicotine dependence presented on 4/6 with cc of AMS. Septic shock suspect secondary to PNA with COVID 19 infection. Also found to have AKI and mastoiditis.      Acute respiratory failure with hypoxia COVID 19 Infection Suspect secondary to PNA and COVID infection CT chest: Extensive multifocal pneumonia. Findings most pronounced in the right lung. Near complete lobar atelectasis/consolidation of the right middle lobe.  transitioned to 5L NC from HHF SpO2 goal 93% or higher Dexamethasone 10 mg for 5 days (stop date: 4/11) Albuterol nebs PRN Pulmonary hygiene ID following,  Started Remdesivir after improvement in creatinine last dose 4/11/23 End of isolation 4/16/2023 Patient eager for discharge.  Attempting to wean off O2. Dc 4/11 after last dose of Remdesevir   Septic shock POA Suspect PNA & Mastoiditis Procalcitonin - 20.10 UA benign but reveals ketones, blood, and hyaline casts MRSA probe, urine antigens, urine culture and sputum NGTD Blood culture coagulase negative staph 1/2 likely contaminant Off levo 4/7 Repeat blood cultures NGTD Cefepime and vancomycin ID following  - recommend 2 weeks clinda and levaquin   Acute Metabolic Encephalopathy, improving  H/o CVA with residual deficits Suspect AMS multifactorial from Presented on 3/12/23 with stroke like symptoms - MRI was negative CT Head Symmetrical lacunar infarcts involving the putamen bilaterally, seen previously. Can be seen in hypoxic injuries or from carbon monoxide, methanol or cyanide toxicity Supportive care  Continue PT, OT  Start ASA Continue Lipitor AKI, improving  NAGMA Initial bicarb 18; likely secondary to AKI Lactate unremarkable, BHB 2.2 potentially starvation ketosis vs AKI Initial VBG pH 7.26, CO2 37, bicarb 17, metabolic acidosis CT nonobstructive NAGMA likely secondary to decreased chloride  Was treated with bicarb drip now discontinued  Creatinine 8.29-- >6.25-- >5.61-- >4.06-- >1.53 -> 0.61 Nephrology followed   Hyponatremia, improving Initial sodium 122, 3 weeks ago sodium was 141, now 136 Serum osm 300, urine osm 293, urine sodium  Trend RFPs Nephrology followed   Right otitis externa Right otitis media Right mastoid effusion Acute sinusitis CT head: Bilateral maxillary sinus air-fluid levels.  There is also right otitis and mastoiditis. Right ear tender to palpation, no erythema no swelling of pinna nor mastoid. Purulent otorrhea from right auditory canal, unable to visualize TM due to otorrhea   Ofloxacin drops BID for 10 days (stop date: 4/16) On Cefepime & Vancomycin  - continue outpatient oral abx therapy as above Hard of hearing on right  ENT & ID following FU ENT after discharge   Elevated BNP Initial BNP 14,000, no comparison Small pericardial effusion seen on CT chest  Echocardiogram results normal EF
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Urine analysis abnormal, Urine antigen test, Urine ketone body present, Urine osmolarity, Urine sodium
Clinical narrative: The patient is a 55 y.o. female with a PMHx of CVA with residual left facial drop, anxiety, DDD, HLD, HTN and nicotine dependence presented on 4/6 with cc of AMS. Septic shock suspect secondary to PNA with COVID 19 infection. Also found to have AKI and mastoiditis.      Acute respiratory failure with hypoxia COVID 19 Infection Suspect secondary to PNA and COVID infection CT chest: Extensive multifocal pneumonia. Findings most pronounced in the right lung. Near complete lobar atelectasis/consolidation of the right middle lobe.  transitioned to 5L NC from HHF SpO2 goal 93% or higher Dexamethasone 10 mg for 5 days (stop date: 4/11) Albuterol nebs PRN Pulmonary hygiene ID following,  Started Remdesivir after improvement in creatinine last dose 4/11/23 End of isolation 4/16/2023 Patient eager for discharge.  Attempting to wean off O2. Dc 4/11 after last dose of Remdesevir   Septic shock POA Suspect PNA & Mastoiditis Procalcitonin - 20.10 UA benign but reveals ketones, blood, and hyaline casts MRSA probe, urine antigens, urine culture and sputum NGTD Blood culture coagulase negative staph 1/2 likely contaminant Off levo 4/7 Repeat blood cultures NGTD Cefepime and vancomycin ID following  - recommend 2 weeks clinda and levaquin   Acute Metabolic Encephalopathy, improving  H/o CVA with residual deficits Suspect AMS multifactorial from Presented on 3/12/23 with stroke like symptoms - MRI was negative CT Head Symmetrical lacunar infarcts involving the putamen bilaterally, seen previously. Can be seen in hypoxic injuries or from carbon monoxide, methanol or cyanide toxicity Supportive care  Continue PT, OT  Start ASA Continue Lipitor AKI, improving  NAGMA Initial bicarb 18; likely secondary to AKI Lactate unremarkable, BHB 2.2 potentially starvation ketosis vs AKI Initial VBG pH 7.26, CO2 37, bicarb 17, metabolic acidosis CT nonobstructive NAGMA likely secondary to decreased chloride  Was treated with bicarb drip now discontinued  Creatinine 8.29-- >6.25-- >5.61-- >4.06-- >1.53 -> 0.61 Nephrology followed   Hyponatremia, improving Initial sodium 122, 3 weeks ago sodium was 141, now 136 Serum osm 300, urine osm 293, urine sodium  Trend RFPs Nephrology followed   Right otitis externa Right otitis media Right mastoid effusion Acute sinusitis CT head: Bilateral maxillary sinus air-fluid levels.  There is also right otitis and mastoiditis. Right ear tender to palpation, no erythema no swelling of pinna nor mastoid. Purulent otorrhea from right auditory canal, unable to visualize TM due to otorrhea   Ofloxacin drops BID for 10 days (stop date: 4/16) On Cefepime & Vancomycin  - continue outpatient oral abx therapy as above Hard of hearing on right  ENT & ID following FU ENT after discharge   Elevated BNP Initial BNP 14,000, no comparison Small pericardial effusion seen on CT chest  Echocardiogram results normal EF
Age: 37.0
Sex: F
Vaccine: SMALL
Symptoms: Amenorrhoea, Blood prolactin increased, Hyperprolactinaemia, Infertility female, Military service
Clinical narrative: Completely healthy menstrual cycle for 37 years. Received small pox vaccine and prolactin shot up rendering me infertile, with no menstrual cycle the same month.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Brain natriuretic peptide, COVID-19, Chest X-ray abnormal, Computerised tomogram thorax normal
Clinical narrative: Clinical Summary  58 y.o. female patient of DO with history of HTN, asthma, HFpEF. Presents with pneumonitis due to covid-19.     Acute Hypoxic Respiratory Failure Concern for Pneumonia, unspecified Pt presents with dyspnea, oxygen requirement, no home O2 PFT 6/2022 no obstruction, mild restriction  Home regimen Albuterol, Breztri, Singulair  CXR: small L pleural effusion with adjacent opacities which could represent PNA vs atelectasis. CT PA with no PE, ground glass opacities in lung bases that appear persistent from prior imaging S/p azithromycin (3/29-4/02) Ambulating comfortably on RA by the time of discharge. Treatment for covid-19 as below Plan OP follow-up with Pulmonary   COVID + Positive  COVID + Positive on resp PCR 3/30 Treated with Azithromycin for possible bacterial component as above Improved and tolerating RA at the time of dc Completed course of Remdesevir PTD Decadron after discharge to complete 10 days   HFpEF BNP reassuring at 170, however patient obese CXR as above CTPA negative Echo with grade I diastolic dysfunction and normal EF, unchanged from previous Continue coreg 3.125 mg BID, losartan, hold spironolactone and torsemide in setting of AKI Diuresed with IV Lasix during the admission Resume home Torsemide after discharge   AKI, resolved Likely due to dehydration in setting of acute illness   HTN Continue home Losartan, Coreg 3.125 BID, holding torsemide and spironolactone   Presumptive OSA Will need sleep study outpatient
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Diastolic dysfunction, Dyspnoea, Echocardiogram abnormal, Ejection fraction normal
Clinical narrative: Clinical Summary  58 y.o. female patient of DO with history of HTN, asthma, HFpEF. Presents with pneumonitis due to covid-19.     Acute Hypoxic Respiratory Failure Concern for Pneumonia, unspecified Pt presents with dyspnea, oxygen requirement, no home O2 PFT 6/2022 no obstruction, mild restriction  Home regimen Albuterol, Breztri, Singulair  CXR: small L pleural effusion with adjacent opacities which could represent PNA vs atelectasis. CT PA with no PE, ground glass opacities in lung bases that appear persistent from prior imaging S/p azithromycin (3/29-4/02) Ambulating comfortably on RA by the time of discharge. Treatment for covid-19 as below Plan OP follow-up with Pulmonary   COVID + Positive  COVID + Positive on resp PCR 3/30 Treated with Azithromycin for possible bacterial component as above Improved and tolerating RA at the time of dc Completed course of Remdesevir PTD Decadron after discharge to complete 10 days   HFpEF BNP reassuring at 170, however patient obese CXR as above CTPA negative Echo with grade I diastolic dysfunction and normal EF, unchanged from previous Continue coreg 3.125 mg BID, losartan, hold spironolactone and torsemide in setting of AKI Diuresed with IV Lasix during the admission Resume home Torsemide after discharge   AKI, resolved Likely due to dehydration in setting of acute illness   HTN Continue home Losartan, Coreg 3.125 BID, holding torsemide and spironolactone   Presumptive OSA Will need sleep study outpatient
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Lung opacity, Pleural effusion, SARS-CoV-2 test positive
Clinical narrative: Clinical Summary  58 y.o. female patient of DO with history of HTN, asthma, HFpEF. Presents with pneumonitis due to covid-19.     Acute Hypoxic Respiratory Failure Concern for Pneumonia, unspecified Pt presents with dyspnea, oxygen requirement, no home O2 PFT 6/2022 no obstruction, mild restriction  Home regimen Albuterol, Breztri, Singulair  CXR: small L pleural effusion with adjacent opacities which could represent PNA vs atelectasis. CT PA with no PE, ground glass opacities in lung bases that appear persistent from prior imaging S/p azithromycin (3/29-4/02) Ambulating comfortably on RA by the time of discharge. Treatment for covid-19 as below Plan OP follow-up with Pulmonary   COVID + Positive  COVID + Positive on resp PCR 3/30 Treated with Azithromycin for possible bacterial component as above Improved and tolerating RA at the time of dc Completed course of Remdesevir PTD Decadron after discharge to complete 10 days   HFpEF BNP reassuring at 170, however patient obese CXR as above CTPA negative Echo with grade I diastolic dysfunction and normal EF, unchanged from previous Continue coreg 3.125 mg BID, losartan, hold spironolactone and torsemide in setting of AKI Diuresed with IV Lasix during the admission Resume home Torsemide after discharge   AKI, resolved Likely due to dehydration in setting of acute illness   HTN Continue home Losartan, Coreg 3.125 BID, holding torsemide and spironolactone   Presumptive OSA Will need sleep study outpatient
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypoxia
Clinical narrative: HYPOXIA
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cardiac imaging procedure abnormal, Cardiac sarcoidosis, Inflammation, Positron emission tomogram abnormal, Ventricular tachycardia
Clinical narrative: I previously reported an event in 2021. I developed heart block after my second Moderna dose in 2021. After my Moderna vaccine (9/21/22) I started to have NSVT events((approx 11/22) on my pacemaker report. My MRI on 02/20/23 shows inflammation consistent with cardiac sarcoidosis. My PET scan on 03/14/23 shows inflammation consistent with cardiac sarcoidosis.  I am now being treated for the condition by a HCP.
Age: 0.5
Sex: F
Vaccine: HEP
Symptoms: Expired product administered
Clinical narrative: expired vaccine give. Expiration date of 5/18/23. Vaccine given on 6/30/23
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Angioedema
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ANGIOEDEMA, SUBSEQ
Age: 0.25
Sex: F
Vaccine: PNC15
Symptoms: Injection site rash
Clinical narrative: Mom sent email along with picture of site.  States that 2 days after vaccine they noticed a rash on patient thigh.  Rash is located only on the left thigh.  Does not seem to bother the patient.  Area is not hot to the touch, patient is afebrile.  Parents have not tried any OTC creams or lotions.  They were encouraged to try Benadryl cream to the area and see if that helps.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchial hyperreactivity, COVID-19, Chest discomfort, Chest pain, Dyspnoea
Clinical narrative: Patient has a history of obesity and diabetes. Notably, she recently arrived from another country (Unknown date of when she moved) and currently lives with her son. She was seen on 4/25/23 in the ED for wheezing, shortness of breath, chest pain, and chest pressure that has been ongoing for about 5 months. Over the past week, her symptoms have been worsening. On arrival to the ED, she was noted to have oxygen saturations in the low 90's and subsequently was placed on 2L O2 via nasal cannula. Additionally, a COVID PCR test performed in the ED resulted positive. She was admitted 4/25/23 - 4/30/23. Discharge diagnoses included acute hypoxia due to COVID-19 with recurrent reactive airway disease. During admission, the patient was able to be weaned to room air. She has received the primary COVID vaccine series, however the lot number for the vaccine is unknown.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, SARS-CoV-2 test positive, Wheezing
Clinical narrative: Patient has a history of obesity and diabetes. Notably, she recently arrived from another country (Unknown date of when she moved) and currently lives with her son. She was seen on 4/25/23 in the ED for wheezing, shortness of breath, chest pain, and chest pressure that has been ongoing for about 5 months. Over the past week, her symptoms have been worsening. On arrival to the ED, she was noted to have oxygen saturations in the low 90's and subsequently was placed on 2L O2 via nasal cannula. Additionally, a COVID PCR test performed in the ED resulted positive. She was admitted 4/25/23 - 4/30/23. Discharge diagnoses included acute hypoxia due to COVID-19 with recurrent reactive airway disease. During admission, the patient was able to be weaned to room air. She has received the primary COVID vaccine series, however the lot number for the vaccine is unknown.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Arthralgia, Arthritis, Gait disturbance, Joint stiffness, Magnetic resonance imaging
Clinical narrative: Diffuse Joint stiffness and pain, limiting ambulation, Arthritis spine, spinal stenosis
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Spinal stenosis, X-ray
Clinical narrative: Diffuse Joint stiffness and pain, limiting ambulation, Arthritis spine, spinal stenosis
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Neuropathy peripheral
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE PERIPHERAL NEUROPATHY
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Alanine aminotransferase increased, Angiogram pulmonary abnormal, Aspartate aminotransferase increased, Blood bilirubin
Clinical narrative: 62 y.o. female patient of, DO with history of HTN, DM, tobacco use, CAD, PAD, COPD. Presents with dyspnea and cough. Found to  be in acute hypoxic respiratory failure, requiring 2LNC 2/2 COVID and COPD exacerbation. Respiratory status initially improved with steroid therapy, but patient continues to require oxygen.    Acute Hypoxic Respiratory Failure Suspected 2/2 covid PNA vs COPD exacerbation  CTPA w/o PE, right upper lobe infilatrates, centrilobular emphysema Additional management as below Required continuous 2L NC oxygen on discharge    Covid 19 Infection Acute COPD exacerbation Positive test on admission, symptom onset 4/4 Completed vaccinations Continued dexamethasone and remdesivir for COVID Continued azithro for COPD exacerbation Duoneb q 4 hr scheduled, IS, mucinex   Hypokalemia - resolved K on admission 2.0 Monitored and repleted as needed   T2DM 4/10 A1c 9.5% Likely worsened hyperglycemia in setting of seroids Home meds: glipizide and metformin, held On day of discharge patient received 74u lantus and 54u SSI Will need close outpatient follow up for titration of medications PCP notified    Hypocalcemia Asymptomatic Ionized calcium 3.3 Phos 2.8, Mag 1.7 Repleted electrolytes PRN   Transaminitis, resolved ALT/AST 51/133, T bili 2.1 on admission Denied daily use of alcohol, no reported hx of w/d seizures Hepatitis panel negative Monitored for signs of w/d Daily CMP Macrocytosis MCV 103 on admission Appeared chronically elevated B12 1784, folate 6.4   HTN Chronic, elevated on admission 2/2 to poor med adherence Asymptomatic  Home medications: lisinopril, metoprolol, Continued metoprolol Held home lisinopril   CAD PAD Hx of SVT Continued home meds with ASA, plavix, atorvastatin  Continued home diltiazem for rate control   Tobacco Use Disorder Smokes 0.5 ppd NRT prn   Multinodular Goiter  Incidentally noted on CT scan  Recommend TSH and US in OP setting
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood folate, Blood magnesium, Blood phosphorus, Blood potassium decreased, COVID-19
Clinical narrative: 62 y.o. female patient of, DO with history of HTN, DM, tobacco use, CAD, PAD, COPD. Presents with dyspnea and cough. Found to  be in acute hypoxic respiratory failure, requiring 2LNC 2/2 COVID and COPD exacerbation. Respiratory status initially improved with steroid therapy, but patient continues to require oxygen.    Acute Hypoxic Respiratory Failure Suspected 2/2 covid PNA vs COPD exacerbation  CTPA w/o PE, right upper lobe infilatrates, centrilobular emphysema Additional management as below Required continuous 2L NC oxygen on discharge    Covid 19 Infection Acute COPD exacerbation Positive test on admission, symptom onset 4/4 Completed vaccinations Continued dexamethasone and remdesivir for COVID Continued azithro for COPD exacerbation Duoneb q 4 hr scheduled, IS, mucinex   Hypokalemia - resolved K on admission 2.0 Monitored and repleted as needed   T2DM 4/10 A1c 9.5% Likely worsened hyperglycemia in setting of seroids Home meds: glipizide and metformin, held On day of discharge patient received 74u lantus and 54u SSI Will need close outpatient follow up for titration of medications PCP notified    Hypocalcemia Asymptomatic Ionized calcium 3.3 Phos 2.8, Mag 1.7 Repleted electrolytes PRN   Transaminitis, resolved ALT/AST 51/133, T bili 2.1 on admission Denied daily use of alcohol, no reported hx of w/d seizures Hepatitis panel negative Monitored for signs of w/d Daily CMP Macrocytosis MCV 103 on admission Appeared chronically elevated B12 1784, folate 6.4   HTN Chronic, elevated on admission 2/2 to poor med adherence Asymptomatic  Home medications: lisinopril, metoprolol, Continued metoprolol Held home lisinopril   CAD PAD Hx of SVT Continued home meds with ASA, plavix, atorvastatin  Continued home diltiazem for rate control   Tobacco Use Disorder Smokes 0.5 ppd NRT prn   Multinodular Goiter  Incidentally noted on CT scan  Recommend TSH and US in OP setting
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19 pneumonia, Calcium ionised, Chronic obstructive pulmonary disease, Condition aggravated, Cough
Clinical narrative: 62 y.o. female patient of, DO with history of HTN, DM, tobacco use, CAD, PAD, COPD. Presents with dyspnea and cough. Found to  be in acute hypoxic respiratory failure, requiring 2LNC 2/2 COVID and COPD exacerbation. Respiratory status initially improved with steroid therapy, but patient continues to require oxygen.    Acute Hypoxic Respiratory Failure Suspected 2/2 covid PNA vs COPD exacerbation  CTPA w/o PE, right upper lobe infilatrates, centrilobular emphysema Additional management as below Required continuous 2L NC oxygen on discharge    Covid 19 Infection Acute COPD exacerbation Positive test on admission, symptom onset 4/4 Completed vaccinations Continued dexamethasone and remdesivir for COVID Continued azithro for COPD exacerbation Duoneb q 4 hr scheduled, IS, mucinex   Hypokalemia - resolved K on admission 2.0 Monitored and repleted as needed   T2DM 4/10 A1c 9.5% Likely worsened hyperglycemia in setting of seroids Home meds: glipizide and metformin, held On day of discharge patient received 74u lantus and 54u SSI Will need close outpatient follow up for titration of medications PCP notified    Hypocalcemia Asymptomatic Ionized calcium 3.3 Phos 2.8, Mag 1.7 Repleted electrolytes PRN   Transaminitis, resolved ALT/AST 51/133, T bili 2.1 on admission Denied daily use of alcohol, no reported hx of w/d seizures Hepatitis panel negative Monitored for signs of w/d Daily CMP Macrocytosis MCV 103 on admission Appeared chronically elevated B12 1784, folate 6.4   HTN Chronic, elevated on admission 2/2 to poor med adherence Asymptomatic  Home medications: lisinopril, metoprolol, Continued metoprolol Held home lisinopril   CAD PAD Hx of SVT Continued home meds with ASA, plavix, atorvastatin  Continued home diltiazem for rate control   Tobacco Use Disorder Smokes 0.5 ppd NRT prn   Multinodular Goiter  Incidentally noted on CT scan  Recommend TSH and US in OP setting
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dyspnoea, Electrolyte substitution therapy, Emphysema, Glycosylated haemoglobin increased, Goitre
Clinical narrative: 62 y.o. female patient of, DO with history of HTN, DM, tobacco use, CAD, PAD, COPD. Presents with dyspnea and cough. Found to  be in acute hypoxic respiratory failure, requiring 2LNC 2/2 COVID and COPD exacerbation. Respiratory status initially improved with steroid therapy, but patient continues to require oxygen.    Acute Hypoxic Respiratory Failure Suspected 2/2 covid PNA vs COPD exacerbation  CTPA w/o PE, right upper lobe infilatrates, centrilobular emphysema Additional management as below Required continuous 2L NC oxygen on discharge    Covid 19 Infection Acute COPD exacerbation Positive test on admission, symptom onset 4/4 Completed vaccinations Continued dexamethasone and remdesivir for COVID Continued azithro for COPD exacerbation Duoneb q 4 hr scheduled, IS, mucinex   Hypokalemia - resolved K on admission 2.0 Monitored and repleted as needed   T2DM 4/10 A1c 9.5% Likely worsened hyperglycemia in setting of seroids Home meds: glipizide and metformin, held On day of discharge patient received 74u lantus and 54u SSI Will need close outpatient follow up for titration of medications PCP notified    Hypocalcemia Asymptomatic Ionized calcium 3.3 Phos 2.8, Mag 1.7 Repleted electrolytes PRN   Transaminitis, resolved ALT/AST 51/133, T bili 2.1 on admission Denied daily use of alcohol, no reported hx of w/d seizures Hepatitis panel negative Monitored for signs of w/d Daily CMP Macrocytosis MCV 103 on admission Appeared chronically elevated B12 1784, folate 6.4   HTN Chronic, elevated on admission 2/2 to poor med adherence Asymptomatic  Home medications: lisinopril, metoprolol, Continued metoprolol Held home lisinopril   CAD PAD Hx of SVT Continued home meds with ASA, plavix, atorvastatin  Continued home diltiazem for rate control   Tobacco Use Disorder Smokes 0.5 ppd NRT prn   Multinodular Goiter  Incidentally noted on CT scan  Recommend TSH and US in OP setting
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hepatitis viral test negative, Hyperglycaemia, Hypertension, Hypertransaminasaemia, Hypocalcaemia
Clinical narrative: 62 y.o. female patient of, DO with history of HTN, DM, tobacco use, CAD, PAD, COPD. Presents with dyspnea and cough. Found to  be in acute hypoxic respiratory failure, requiring 2LNC 2/2 COVID and COPD exacerbation. Respiratory status initially improved with steroid therapy, but patient continues to require oxygen.    Acute Hypoxic Respiratory Failure Suspected 2/2 covid PNA vs COPD exacerbation  CTPA w/o PE, right upper lobe infilatrates, centrilobular emphysema Additional management as below Required continuous 2L NC oxygen on discharge    Covid 19 Infection Acute COPD exacerbation Positive test on admission, symptom onset 4/4 Completed vaccinations Continued dexamethasone and remdesivir for COVID Continued azithro for COPD exacerbation Duoneb q 4 hr scheduled, IS, mucinex   Hypokalemia - resolved K on admission 2.0 Monitored and repleted as needed   T2DM 4/10 A1c 9.5% Likely worsened hyperglycemia in setting of seroids Home meds: glipizide and metformin, held On day of discharge patient received 74u lantus and 54u SSI Will need close outpatient follow up for titration of medications PCP notified    Hypocalcemia Asymptomatic Ionized calcium 3.3 Phos 2.8, Mag 1.7 Repleted electrolytes PRN   Transaminitis, resolved ALT/AST 51/133, T bili 2.1 on admission Denied daily use of alcohol, no reported hx of w/d seizures Hepatitis panel negative Monitored for signs of w/d Daily CMP Macrocytosis MCV 103 on admission Appeared chronically elevated B12 1784, folate 6.4   HTN Chronic, elevated on admission 2/2 to poor med adherence Asymptomatic  Home medications: lisinopril, metoprolol, Continued metoprolol Held home lisinopril   CAD PAD Hx of SVT Continued home meds with ASA, plavix, atorvastatin  Continued home diltiazem for rate control   Tobacco Use Disorder Smokes 0.5 ppd NRT prn   Multinodular Goiter  Incidentally noted on CT scan  Recommend TSH and US in OP setting
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypokalaemia, Lung infiltration, Macrocytosis, Malaise, Mean cell volume increased
Clinical narrative: 62 y.o. female patient of, DO with history of HTN, DM, tobacco use, CAD, PAD, COPD. Presents with dyspnea and cough. Found to  be in acute hypoxic respiratory failure, requiring 2LNC 2/2 COVID and COPD exacerbation. Respiratory status initially improved with steroid therapy, but patient continues to require oxygen.    Acute Hypoxic Respiratory Failure Suspected 2/2 covid PNA vs COPD exacerbation  CTPA w/o PE, right upper lobe infilatrates, centrilobular emphysema Additional management as below Required continuous 2L NC oxygen on discharge    Covid 19 Infection Acute COPD exacerbation Positive test on admission, symptom onset 4/4 Completed vaccinations Continued dexamethasone and remdesivir for COVID Continued azithro for COPD exacerbation Duoneb q 4 hr scheduled, IS, mucinex   Hypokalemia - resolved K on admission 2.0 Monitored and repleted as needed   T2DM 4/10 A1c 9.5% Likely worsened hyperglycemia in setting of seroids Home meds: glipizide and metformin, held On day of discharge patient received 74u lantus and 54u SSI Will need close outpatient follow up for titration of medications PCP notified    Hypocalcemia Asymptomatic Ionized calcium 3.3 Phos 2.8, Mag 1.7 Repleted electrolytes PRN   Transaminitis, resolved ALT/AST 51/133, T bili 2.1 on admission Denied daily use of alcohol, no reported hx of w/d seizures Hepatitis panel negative Monitored for signs of w/d Daily CMP Macrocytosis MCV 103 on admission Appeared chronically elevated B12 1784, folate 6.4   HTN Chronic, elevated on admission 2/2 to poor med adherence Asymptomatic  Home medications: lisinopril, metoprolol, Continued metoprolol Held home lisinopril   CAD PAD Hx of SVT Continued home meds with ASA, plavix, atorvastatin  Continued home diltiazem for rate control   Tobacco Use Disorder Smokes 0.5 ppd NRT prn   Multinodular Goiter  Incidentally noted on CT scan  Recommend TSH and US in OP setting
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Metabolic function test, SARS-CoV-2 test positive, Vitamin B12 increased
Clinical narrative: 62 y.o. female patient of, DO with history of HTN, DM, tobacco use, CAD, PAD, COPD. Presents with dyspnea and cough. Found to  be in acute hypoxic respiratory failure, requiring 2LNC 2/2 COVID and COPD exacerbation. Respiratory status initially improved with steroid therapy, but patient continues to require oxygen.    Acute Hypoxic Respiratory Failure Suspected 2/2 covid PNA vs COPD exacerbation  CTPA w/o PE, right upper lobe infilatrates, centrilobular emphysema Additional management as below Required continuous 2L NC oxygen on discharge    Covid 19 Infection Acute COPD exacerbation Positive test on admission, symptom onset 4/4 Completed vaccinations Continued dexamethasone and remdesivir for COVID Continued azithro for COPD exacerbation Duoneb q 4 hr scheduled, IS, mucinex   Hypokalemia - resolved K on admission 2.0 Monitored and repleted as needed   T2DM 4/10 A1c 9.5% Likely worsened hyperglycemia in setting of seroids Home meds: glipizide and metformin, held On day of discharge patient received 74u lantus and 54u SSI Will need close outpatient follow up for titration of medications PCP notified    Hypocalcemia Asymptomatic Ionized calcium 3.3 Phos 2.8, Mag 1.7 Repleted electrolytes PRN   Transaminitis, resolved ALT/AST 51/133, T bili 2.1 on admission Denied daily use of alcohol, no reported hx of w/d seizures Hepatitis panel negative Monitored for signs of w/d Daily CMP Macrocytosis MCV 103 on admission Appeared chronically elevated B12 1784, folate 6.4   HTN Chronic, elevated on admission 2/2 to poor med adherence Asymptomatic  Home medications: lisinopril, metoprolol, Continued metoprolol Held home lisinopril   CAD PAD Hx of SVT Continued home meds with ASA, plavix, atorvastatin  Continued home diltiazem for rate control   Tobacco Use Disorder Smokes 0.5 ppd NRT prn   Multinodular Goiter  Incidentally noted on CT scan  Recommend TSH and US in OP setting
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Angina pectoris, Symptom recurrence
Clinical narrative: ANGINA, UNSPECIFIED 1/29/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, COVID-19, Depressed level of consciousness, Encephalopathy, Endotracheal intubation
Clinical narrative: Patient is a 72 y.o. female with history of Lewy body dementia who presented from home on 3/14/2023 with acute hypoxemic respiratory failure and found to be COVID-positive with superimposed bacterial pneumonia.  Patient had a prolonged hospital course due to acute on chronic encephalopathy, severe sepsis and aspiration pneumonia.  She was intubated while in ICU, unable to wean. Family opted for DNR CC after GOC discussions with Palliative team.  Patient was discharged to the inpatient hospice team at a local HCF.   Acute hypoxic respiratory failure COVID infection Aspiration pneumonia Septic shock -Patient was admitted for hypoxemia and found to have COVID-positive infection.  -Transferred to ICU, intubated.  Hospital course was prolonged due to inability to wean, acute on chronic encephalopathy -Patient was extubated after extensive goals of care discussion with palliative team.  Patient is currently DNR CC   Lewy body dementia Acute on chronic encephalopathy -Known history, she is currently obtunded -Comfort meds in place   Essential hypertension -She needed vasopressor support for septic shock while in ICU -Home Coreg held
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Essential hypertension, Hypoxia, Intensive care, Pneumonia aspiration, Pneumonia bacterial
Clinical narrative: Patient is a 72 y.o. female with history of Lewy body dementia who presented from home on 3/14/2023 with acute hypoxemic respiratory failure and found to be COVID-positive with superimposed bacterial pneumonia.  Patient had a prolonged hospital course due to acute on chronic encephalopathy, severe sepsis and aspiration pneumonia.  She was intubated while in ICU, unable to wean. Family opted for DNR CC after GOC discussions with Palliative team.  Patient was discharged to the inpatient hospice team at a local HCF.   Acute hypoxic respiratory failure COVID infection Aspiration pneumonia Septic shock -Patient was admitted for hypoxemia and found to have COVID-positive infection.  -Transferred to ICU, intubated.  Hospital course was prolonged due to inability to wean, acute on chronic encephalopathy -Patient was extubated after extensive goals of care discussion with palliative team.  Patient is currently DNR CC   Lewy body dementia Acute on chronic encephalopathy -Known history, she is currently obtunded -Comfort meds in place   Essential hypertension -She needed vasopressor support for septic shock while in ICU -Home Coreg held
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Sepsis, Septic shock, Superinfection
Clinical narrative: Patient is a 72 y.o. female with history of Lewy body dementia who presented from home on 3/14/2023 with acute hypoxemic respiratory failure and found to be COVID-positive with superimposed bacterial pneumonia.  Patient had a prolonged hospital course due to acute on chronic encephalopathy, severe sepsis and aspiration pneumonia.  She was intubated while in ICU, unable to wean. Family opted for DNR CC after GOC discussions with Palliative team.  Patient was discharged to the inpatient hospice team at a local HCF.   Acute hypoxic respiratory failure COVID infection Aspiration pneumonia Septic shock -Patient was admitted for hypoxemia and found to have COVID-positive infection.  -Transferred to ICU, intubated.  Hospital course was prolonged due to inability to wean, acute on chronic encephalopathy -Patient was extubated after extensive goals of care discussion with palliative team.  Patient is currently DNR CC   Lewy body dementia Acute on chronic encephalopathy -Known history, she is currently obtunded -Comfort meds in place   Essential hypertension -She needed vasopressor support for septic shock while in ICU -Home Coreg held
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Coronary arterial stent insertion, Coronary artery occlusion, General physical health deterioration, Myocardial infarction
Clinical narrative: Suffered 100% blockage of Right Coronary Artery requiring stent to be placed.  Had not been feeling well before I took the two Moderna shots.  Never felt better after the 2nd Moderna shot and was progressively getting worse until heart attack.
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: OBSTRUCTIVE SLEEP APNEA
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE ST ELEVATION MI, ANTERIOR WALL
Age: 21.0
Sex: F
Vaccine: VARZOS
Symptoms: Depression, Suicidal ideation
Clinical narrative: pt went to ED for depression and suicidal thoughts
Age: 85.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Anaemia, Atrial fibrillation, Blood creatinine, Blood loss anaemia
Clinical narrative: Patient is a 85 y.o. female patient of, MD with history of CAD, CKD 3, DM 2, GERD, hyperlipidemia, CHF, hypertension, PVD, OSA presented on 3/31/2023 with hip fracture.  Found to have COVID with hypoxia.  Treated with Decadron and remdesivir, clinically improved, saturating well on room air for the last 24 hours, feels comfortable going home instead of rehab   Right hip FNS implant failure S/p right hip removal of hardware and hemiarthroplasty Continue postop care as per Ortho Continue PT OT   Acute respiratory failure with hypoxia Covid-19 Virus Infection Date of onset of symptoms: Asymptomatic Symptoms present on admission: Asymptomatic Date of covid positive test: 4/2/2023 Vaccination status: vaccinated Imaging: Chest x-ray 4/4/2023no abnormality Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: Decadron and remdesivir 4/4/2023-4/5/23 Consultants following: None Anticipated special isolation end date: 4/11/2023   Acute on chronic HFpEF CAD s/p CABG and stent to RCA PVD Responding well to IV Lasix Switch back to home dose of Lasix 40 mg p.o. twice daily  Echo 8/2022 LVEF 60% Continue asa, statin, lasix, imdur, metoprolol, nifedipine, Entresto   Orthostatic hypotensionresolved Blood pressure dropped on 4/2, 4/3 after working with physical therapy Responded well to IV fluid bolus Clinically improving, feels comfortable going home Continue nifedipine and metoprolol with holding parameters     DM2 A1c 7.4 SSI Diabetic diet   CKD3b Scr 1.62 Baseline range from 1.4-1.6 Monitor renal function Encourage p.o. hydration, holding Lasix, Entresto    Acute on chronic anemia Anemia of chronic kidney disease worsened secondary to blood loss associated from surgery Hemoglobin 8.9<9.0<10.1 Continue to monitor   Chronic afib Rate controlled Asa, plavix   OSA CPAP ordered
Age: 85.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood pressure decreased, COVID-19, Cardiac failure, Cardiac failure acute, Chest X-ray normal
Clinical narrative: Patient is a 85 y.o. female patient of, MD with history of CAD, CKD 3, DM 2, GERD, hyperlipidemia, CHF, hypertension, PVD, OSA presented on 3/31/2023 with hip fracture.  Found to have COVID with hypoxia.  Treated with Decadron and remdesivir, clinically improved, saturating well on room air for the last 24 hours, feels comfortable going home instead of rehab   Right hip FNS implant failure S/p right hip removal of hardware and hemiarthroplasty Continue postop care as per Ortho Continue PT OT   Acute respiratory failure with hypoxia Covid-19 Virus Infection Date of onset of symptoms: Asymptomatic Symptoms present on admission: Asymptomatic Date of covid positive test: 4/2/2023 Vaccination status: vaccinated Imaging: Chest x-ray 4/4/2023no abnormality Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: Decadron and remdesivir 4/4/2023-4/5/23 Consultants following: None Anticipated special isolation end date: 4/11/2023   Acute on chronic HFpEF CAD s/p CABG and stent to RCA PVD Responding well to IV Lasix Switch back to home dose of Lasix 40 mg p.o. twice daily  Echo 8/2022 LVEF 60% Continue asa, statin, lasix, imdur, metoprolol, nifedipine, Entresto   Orthostatic hypotensionresolved Blood pressure dropped on 4/2, 4/3 after working with physical therapy Responded well to IV fluid bolus Clinically improving, feels comfortable going home Continue nifedipine and metoprolol with holding parameters     DM2 A1c 7.4 SSI Diabetic diet   CKD3b Scr 1.62 Baseline range from 1.4-1.6 Monitor renal function Encourage p.o. hydration, holding Lasix, Entresto    Acute on chronic anemia Anemia of chronic kidney disease worsened secondary to blood loss associated from surgery Hemoglobin 8.9<9.0<10.1 Continue to monitor   Chronic afib Rate controlled Asa, plavix   OSA CPAP ordered
Age: 85.0
Sex: F
Vaccine: COVID19-2
Symptoms: Condition aggravated, Coronary arterial stent insertion, Coronary artery bypass, Coronary artery disease, Device failure
Clinical narrative: Patient is a 85 y.o. female patient of, MD with history of CAD, CKD 3, DM 2, GERD, hyperlipidemia, CHF, hypertension, PVD, OSA presented on 3/31/2023 with hip fracture.  Found to have COVID with hypoxia.  Treated with Decadron and remdesivir, clinically improved, saturating well on room air for the last 24 hours, feels comfortable going home instead of rehab   Right hip FNS implant failure S/p right hip removal of hardware and hemiarthroplasty Continue postop care as per Ortho Continue PT OT   Acute respiratory failure with hypoxia Covid-19 Virus Infection Date of onset of symptoms: Asymptomatic Symptoms present on admission: Asymptomatic Date of covid positive test: 4/2/2023 Vaccination status: vaccinated Imaging: Chest x-ray 4/4/2023no abnormality Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: Decadron and remdesivir 4/4/2023-4/5/23 Consultants following: None Anticipated special isolation end date: 4/11/2023   Acute on chronic HFpEF CAD s/p CABG and stent to RCA PVD Responding well to IV Lasix Switch back to home dose of Lasix 40 mg p.o. twice daily  Echo 8/2022 LVEF 60% Continue asa, statin, lasix, imdur, metoprolol, nifedipine, Entresto   Orthostatic hypotensionresolved Blood pressure dropped on 4/2, 4/3 after working with physical therapy Responded well to IV fluid bolus Clinically improving, feels comfortable going home Continue nifedipine and metoprolol with holding parameters     DM2 A1c 7.4 SSI Diabetic diet   CKD3b Scr 1.62 Baseline range from 1.4-1.6 Monitor renal function Encourage p.o. hydration, holding Lasix, Entresto    Acute on chronic anemia Anemia of chronic kidney disease worsened secondary to blood loss associated from surgery Hemoglobin 8.9<9.0<10.1 Continue to monitor   Chronic afib Rate controlled Asa, plavix   OSA CPAP ordered
Age: 85.0
Sex: F
Vaccine: COVID19-2
Symptoms: Diabetic diet, Echocardiogram normal, Ejection fraction, Glycosylated haemoglobin increased, Haemoglobin decreased
Clinical narrative: Patient is a 85 y.o. female patient of, MD with history of CAD, CKD 3, DM 2, GERD, hyperlipidemia, CHF, hypertension, PVD, OSA presented on 3/31/2023 with hip fracture.  Found to have COVID with hypoxia.  Treated with Decadron and remdesivir, clinically improved, saturating well on room air for the last 24 hours, feels comfortable going home instead of rehab   Right hip FNS implant failure S/p right hip removal of hardware and hemiarthroplasty Continue postop care as per Ortho Continue PT OT   Acute respiratory failure with hypoxia Covid-19 Virus Infection Date of onset of symptoms: Asymptomatic Symptoms present on admission: Asymptomatic Date of covid positive test: 4/2/2023 Vaccination status: vaccinated Imaging: Chest x-ray 4/4/2023no abnormality Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: Decadron and remdesivir 4/4/2023-4/5/23 Consultants following: None Anticipated special isolation end date: 4/11/2023   Acute on chronic HFpEF CAD s/p CABG and stent to RCA PVD Responding well to IV Lasix Switch back to home dose of Lasix 40 mg p.o. twice daily  Echo 8/2022 LVEF 60% Continue asa, statin, lasix, imdur, metoprolol, nifedipine, Entresto   Orthostatic hypotensionresolved Blood pressure dropped on 4/2, 4/3 after working with physical therapy Responded well to IV fluid bolus Clinically improving, feels comfortable going home Continue nifedipine and metoprolol with holding parameters     DM2 A1c 7.4 SSI Diabetic diet   CKD3b Scr 1.62 Baseline range from 1.4-1.6 Monitor renal function Encourage p.o. hydration, holding Lasix, Entresto    Acute on chronic anemia Anemia of chronic kidney disease worsened secondary to blood loss associated from surgery Hemoglobin 8.9<9.0<10.1 Continue to monitor   Chronic afib Rate controlled Asa, plavix   OSA CPAP ordered
Age: 85.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hip arthroplasty, Hip fracture, Hypoxia, Medical device removal, Nephrogenic anaemia
Clinical narrative: Patient is a 85 y.o. female patient of, MD with history of CAD, CKD 3, DM 2, GERD, hyperlipidemia, CHF, hypertension, PVD, OSA presented on 3/31/2023 with hip fracture.  Found to have COVID with hypoxia.  Treated with Decadron and remdesivir, clinically improved, saturating well on room air for the last 24 hours, feels comfortable going home instead of rehab   Right hip FNS implant failure S/p right hip removal of hardware and hemiarthroplasty Continue postop care as per Ortho Continue PT OT   Acute respiratory failure with hypoxia Covid-19 Virus Infection Date of onset of symptoms: Asymptomatic Symptoms present on admission: Asymptomatic Date of covid positive test: 4/2/2023 Vaccination status: vaccinated Imaging: Chest x-ray 4/4/2023no abnormality Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: Decadron and remdesivir 4/4/2023-4/5/23 Consultants following: None Anticipated special isolation end date: 4/11/2023   Acute on chronic HFpEF CAD s/p CABG and stent to RCA PVD Responding well to IV Lasix Switch back to home dose of Lasix 40 mg p.o. twice daily  Echo 8/2022 LVEF 60% Continue asa, statin, lasix, imdur, metoprolol, nifedipine, Entresto   Orthostatic hypotensionresolved Blood pressure dropped on 4/2, 4/3 after working with physical therapy Responded well to IV fluid bolus Clinically improving, feels comfortable going home Continue nifedipine and metoprolol with holding parameters     DM2 A1c 7.4 SSI Diabetic diet   CKD3b Scr 1.62 Baseline range from 1.4-1.6 Monitor renal function Encourage p.o. hydration, holding Lasix, Entresto    Acute on chronic anemia Anemia of chronic kidney disease worsened secondary to blood loss associated from surgery Hemoglobin 8.9<9.0<10.1 Continue to monitor   Chronic afib Rate controlled Asa, plavix   OSA CPAP ordered
Age: 85.0
Sex: F
Vaccine: COVID19-2
Symptoms: Obstructive sleep apnoea syndrome, Orthostatic hypotension, Peripheral vascular disorder, SARS-CoV-2 test positive
Clinical narrative: Patient is a 85 y.o. female patient of, MD with history of CAD, CKD 3, DM 2, GERD, hyperlipidemia, CHF, hypertension, PVD, OSA presented on 3/31/2023 with hip fracture.  Found to have COVID with hypoxia.  Treated with Decadron and remdesivir, clinically improved, saturating well on room air for the last 24 hours, feels comfortable going home instead of rehab   Right hip FNS implant failure S/p right hip removal of hardware and hemiarthroplasty Continue postop care as per Ortho Continue PT OT   Acute respiratory failure with hypoxia Covid-19 Virus Infection Date of onset of symptoms: Asymptomatic Symptoms present on admission: Asymptomatic Date of covid positive test: 4/2/2023 Vaccination status: vaccinated Imaging: Chest x-ray 4/4/2023no abnormality Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: Decadron and remdesivir 4/4/2023-4/5/23 Consultants following: None Anticipated special isolation end date: 4/11/2023   Acute on chronic HFpEF CAD s/p CABG and stent to RCA PVD Responding well to IV Lasix Switch back to home dose of Lasix 40 mg p.o. twice daily  Echo 8/2022 LVEF 60% Continue asa, statin, lasix, imdur, metoprolol, nifedipine, Entresto   Orthostatic hypotensionresolved Blood pressure dropped on 4/2, 4/3 after working with physical therapy Responded well to IV fluid bolus Clinically improving, feels comfortable going home Continue nifedipine and metoprolol with holding parameters     DM2 A1c 7.4 SSI Diabetic diet   CKD3b Scr 1.62 Baseline range from 1.4-1.6 Monitor renal function Encourage p.o. hydration, holding Lasix, Entresto    Acute on chronic anemia Anemia of chronic kidney disease worsened secondary to blood loss associated from surgery Hemoglobin 8.9<9.0<10.1 Continue to monitor   Chronic afib Rate controlled Asa, plavix   OSA CPAP ordered
Sex: F
Vaccine: HEPA
Symptoms: Wrong product administered
Clinical narrative: Hep A given instead of Hepatitis B.  Medical Assistant handed the wrong vaccine to the administering MA.
Age: 12.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: The vaccine that was administer was accidently stored improperly. No adverse reactions.